학술논문
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways
Document Type
Article
Author
Source
In Translational Oncology February 2024 40
Subject
Language
ISSN
1936-5233